Clinical Edge Journal Scan

No link between vitamin D levels at birth and early adulthood RA risk


 

Key clinical point: Vitamin D concentration at birth was not associated with the risk of developing rheumatoid arthritis (RA) in early adulthood.

Major finding: The risk of developing RA in individuals aged 18-33.9 years was not significantly different among those in the highest vs. lowest vitamin D quintile (adjusted hazard ratio 1.21; 95% CI 0.90-1.63).

Study details: This was a registry-based case-cohort study involving 805 patients with RA with onset in early adulthood and 2,416 individuals from a random subcohort.

Disclosures: This research was supported by the Danish Rheumatism Association and others. The authors declared no conflicts of interest.

Source: Cardoso I et al . Nutrients. 2022;14(3):447 (Jan 20). Doi: 10.3390/nu14030447

Recommended Reading

Patients are interrupting DMARD use well into the COVID-19 pandemic
MDedge Rheumatology
Treat-to-target in RA: Questions remain about adoption, measurement
MDedge Rheumatology
Rheumatoid arthritis: Higher risk for MACE and cancer with tofacitinib vs. TNF inhibitors
MDedge Rheumatology
More evidence supporting ultra-low retreatment dose of rituximab in RA
MDedge Rheumatology
Acute exacerbation affects prognosis in RA-associated interstitial lung disease
MDedge Rheumatology
A real-world analysis finds no evidence of increased CV risk with tofacitinib vs. TNFi in RA
MDedge Rheumatology
Early RA: Prevalence and factors associated with methotrexate-related adverse events
MDedge Rheumatology
A healthy lifestyle may prevent the development of RA
MDedge Rheumatology
DMARDs or corticosteroids use may not explain reduced risk for Parkinson disease in RA
MDedge Rheumatology
Low disease activity tied to increased bone mineral density in RA
MDedge Rheumatology